OFIX Logo

Orthofix Medical Inc. (OFIX) 

NASDAQ
Market Cap
$699.36M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
650 of 776
Rank in Industry
85 of 100

Largest Insider Buys in Sector

OFIX Stock Price History Chart

OFIX Stock Performance

About Orthofix Medical Inc.

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion …

Insider Activity of Orthofix Medical Inc.

Over the last 12 months, insiders at Orthofix Medical Inc. have bought $0 and sold $0 worth of Orthofix Medical Inc. stock.

On average, over the past 5 years, insiders at Orthofix Medical Inc. have bought $398,117 and sold $279,795 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 7,500 shares for transaction amount of $101,025 was made by Hinrichs James F. (director) on 2023‑09‑14.

List of Insider Buy and Sell Transactions, Orthofix Medical Inc.

2023-09-14Purchasedirector
7,500
0.0209%
$13.47$101,025+2.62%
2023-05-26SalePresident of Global Spine
3,876
0.0109%
$19.00$73,644-26.41%
2023-05-24SalePresident of Global Spine
4,367
0.0124%
$19.00$82,973-26.13%
2023-03-10Saledirector
4,262
0.012%
$17.75$75,651-12.41%
2021-11-22Purchasedirector
2,000
0.0098%
$31.15$62,300-15.70%
2021-11-19PurchaseCFO
1,400
0.0069%
$30.05$42,070-12.36%
2021-11-19Purchasedirector
1,660
0.0082%
$30.27$50,248-12.36%
2021-11-18PurchaseCEO
1,670
0.0088%
$31.14$52,004-9.28%
2021-11-18PurchaseChief Legal & Develop. Officer
1,000
0.0051%
$30.34$30,340-9.28%
2020-06-05SaleChief Strategy Officer
8,750
0.0454%
$37.41$327,323+1.54%
2020-03-16Purchasedirector
20,000
0.1056%
$24.25$485,000+41.92%
2020-03-12Purchasedirector
10,000
0.052%
$26.85$268,469+26.12%
2020-02-27PurchaseCEO
2,900
0.015%
$35.48$102,895-6.27%
2019-10-31Purchasedirector
20,000
0.1064%
$42.27$845,305-19.47%
2019-08-28SaleCEO
5,805
0.0307%
$50.97$295,874-28.03%
2019-06-13SaleCEO
17,780
0.0937%
$51.11$908,654-11.87%
2019-05-14SaleCEO
21,336
0.113%
$53.71$1.15M-13.57%
2019-04-17SaleCEO
11,898
0.0627%
$52.35$622,888-5.87%
2019-02-19SalePresident, Global Extremities
48,398
0.2562%
$65.00$3.15M-21.76%
2019-02-15SalePresident, Global Extremities
402
0.0022%
$65.00$26,130-20.48%

Insider Historical Profitability

<0.0001%
Mason BradCEO
165041
0.4323%
$18.32116<0.0001%
GERO JAMESdirector
156630
0.4103%
$18.3290<0.0001%
MATRICARIA RONALD Adirector
154939
0.4059%
$18.3250+12.76%
Serbousek Jon CarlCEO
112812
0.2955%
$18.3220<0.0001%
Hinrichs James F.director
86153
0.2257%
$18.3230+20.2%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Armistice Capital Llc$53.72M9.863.7M+2.78%+$1.45M0.17
Helm Capital Management LLC$53.22M9.773.67M0%+$01.57
BlackRock$47.82M8.783.29M-0.73%-$349,772.28<0.01
Engine Capital Management Lp$44.07M8.093.04M0%+$08.9
Morgan Stanley$40.07M7.352.76M+31.86%+$9.68M<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.